(MENAFN- GlobeNewsWire - Nasdaq) Veteran FDA and Industry Leader to Guide Late-Stage Programs, Including First-In-Class Non-Addictive Analgesic DMX-101 SAN FRANCISCO, Dec. 03, 2025 (GLOBE NEWSWIRE) -- ...

SAN FRANCISCO, Dec. 03, 2025 (GLOBE NEWSWIRE) -- DIMERx, Inc. (“DIMERx”), a clinical-stage biopharmaceutical company developing first-in-class dimer-based therapeutics for major public-health needs, ...

SAN FRANCISCO, Dec. 03, 2025 (GLOBE NEWSWIRE) -- DIMERx, Inc. ("DIMERx”), a clinical-stage biopharmaceutical company developing first-in-class dimer-based therapeutics for major public-health needs, ...

Utah State University has introduced a pioneering program focused on air traffic control within their aviation management curriculum. FOX 13 News Reporter Mythili Gubbi explores the impact of this ...

The Federal Aviation Administration has long struggled with a shortage of air traffic controllers and the recent government shutdown has only exacerbated the crisis. Controllers were forced to work ...

The new Steam Controller is a smart way to play PC games on the sofa, stealing the Steam Deck's clever controls. When you purchase through links on our site, we may earn an affiliate commission.

TOLEDO, Ohio — The Area Office on Aging of Northwestern Ohio and the Ohio Department of Development are reminding older residents that help is available to manage home energy costs through the Winter ...

The layoffs have raised fears that the administration could be effectively ending an initiative that provides contraception for millions of low-income women. By Caroline Kitchener Reporting from ...

Apple previously announced the Logitech Muse stylus for Vision Pro and added PSVR 2 controller support to VisionOS 26. Now we have an official release date for the stylus and a package of PSVR 2 ...

This article is part of Kotaku Deals, produced separately from the editorial team. We may earn a commission when you buy through links on the site. Gaming with friends is only fun when everyone has a ...

Amicus Therapeutics (NASDAQ:FOLD) was upgraded to Buy from Hold at Needham with a $14 target, emphasizing that the company's kidney disease program, DMX-200, is undervalued. The stock of the company ...